AN2 Therapeutics to Participate at Upcoming Investor Conferences
AN2 Therapeutics (Nasdaq: ANTX), a biopharmaceutical company specializing in boron chemistry platform-derived small molecule therapeutics, has announced its participation in two major investor conferences in March 2025.
At the TD Cowen 45th Annual Health Care Conference, Co-Founder, Chairman, President and CEO Eric Easom will deliver a corporate overview on March 3, 2025, at 2:30 pm ET. The management team will also be available for one-on-one meetings.
The company will also attend the Leerink Partners Global Healthcare Conference on March 12, 2025, where management will conduct one-on-one meetings. The TD Cowen conference presentation will be webcasted and accessible through AN2 Therapeutics' website, with a replay available for at least 30 days post-presentation.
AN2 Therapeutics (Nasdaq: ANTX), un'azienda biopharmaceutica specializzata in terapie a base di piccole molecole derivate da una piattaforma di chimica del boro, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel marzo 2025.
Alla 45ª Conferenza Annuale sulla Salute di TD Cowen, il co-fondatore, presidente e CEO Eric Easom presenterà una panoramica aziendale il 3 marzo 2025, alle 14:30 ET. Il team di gestione sarà disponibile anche per incontri one-to-one.
L'azienda parteciperà anche alla Conferenza Globale sulla Salute di Leerink Partners il 12 marzo 2025, dove la direzione condurrà incontri individuali. La presentazione della conferenza TD Cowen sarà trasmessa in webcast e accessibile attraverso il sito web di AN2 Therapeutics, con una registrazione disponibile per almeno 30 giorni dopo la presentazione.
AN2 Therapeutics (Nasdaq: ANTX), una empresa biofarmacéutica especializada en terapias de pequeñas moléculas derivadas de una plataforma de química de boro, ha anunciado su participación en dos importantes conferencias para inversores en marzo de 2025.
En la 45ª Conferencia Anual de Atención Médica de TD Cowen, el cofundador, presidente y CEO Eric Easom ofrecerá una visión general de la empresa el 3 de marzo de 2025, a las 2:30 p. m. ET. El equipo de gestión también estará disponible para reuniones individuales.
La empresa también asistirá a la Conferencia Global de Atención Médica de Leerink Partners el 12 de marzo de 2025, donde la dirección llevará a cabo reuniones uno a uno. La presentación de la conferencia de TD Cowen será transmitida por webcast y estará accesible a través del sitio web de AN2 Therapeutics, con una repetición disponible durante al menos 30 días después de la presentación.
AN2 Therapeutics (Nasdaq: ANTX), 보론 화학 플랫폼에서 유래한 소분자 치료제를 전문으로 하는 생명공학 회사는 2025년 3월에 두 개의 주요 투자자 회의에 참여한다고 발표했습니다.
TD Cowen 제45회 연례 의료 회의에서 공동 창립자이자 회장, 사장 및 CEO인 Eric Easom이 2025년 3월 3일 오후 2시 30분 ET에 회사 개요를 발표할 예정입니다. 관리 팀은 일대일 회의도 진행할 수 있습니다.
회사는 또한 2025년 3월 12일 Leerink Partners 글로벌 의료 회의에 참석하여 관리 팀이 일대일 회의를 진행할 것입니다. TD Cowen 회의 발표는 웹캐스트로 방송되며 AN2 Therapeutics의 웹사이트를 통해 접근할 수 있으며, 발표 후 최소 30일 동안 재생이 가능합니다.
AN2 Therapeutics (Nasdaq: ANTX), une entreprise biopharmaceutique spécialisée dans les thérapies à base de petites molécules dérivées d'une plateforme de chimie du bore, a annoncé sa participation à deux grandes conférences pour investisseurs en mars 2025.
Lors de la 45e Conférence Annuelle sur la Santé de TD Cowen, le co-fondateur, président et PDG Eric Easom présentera un aperçu de l'entreprise le 3 mars 2025 à 14h30 ET. L'équipe de direction sera également disponible pour des réunions individuelles.
L'entreprise participera également à la Conférence Mondiale sur la Santé de Leerink Partners le 12 mars 2025, où la direction tiendra des réunions individuelles. La présentation de la conférence TD Cowen sera diffusée en direct et accessible via le site Web d'AN2 Therapeutics, avec une rediffusion disponible pendant au moins 30 jours après la présentation.
AN2 Therapeutics (Nasdaq: ANTX), ein biopharmazeutisches Unternehmen, das sich auf therapeutische kleine Moleküle aus einer Borchemie-Plattform spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt.
Auf der 45. jährlichen Gesundheitskonferenz von TD Cowen wird Mitbegründer, Vorsitzender, Präsident und CEO Eric Easom am 3. März 2025 um 14:30 Uhr ET einen Unternehmensüberblick präsentieren. Das Managementteam wird auch für Einzelgespräche zur Verfügung stehen.
Das Unternehmen wird auch an der Leerink Partners Global Healthcare Conference am 12. März 2025 teilnehmen, wo das Management Einzelgespräche führen wird. Die Präsentation der TD Cowen-Konferenz wird als Webcast übertragen und über die Website von AN2 Therapeutics zugänglich sein, mit einer Wiederholung, die mindestens 30 Tage nach der Präsentation verfügbar ist.
- None.
- None.
Details of the events are as follows:
TD Cowen 45th Annual Health Care Conference
- Eric Easom, Co-Founder, Chairman, President and CEO will provide a corporate overview on Monday, March 3, 2025 at 2:30 pm ET, and members of management will be available for 1X1 meetings.
Leerink Partners Global Healthcare Conference
- Members of management will be available for 1X1 meetings on Wednesday, March 12, 2025.
A webcast of the Cowen Health Care Conference presentation can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com. An archived replay will be available for at least 30 days following the presentation.
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. AN2 has a pipeline of boron-based compounds in development for Chagas disease, NTM, and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. For more information, please visit our website at www.an2therapeutics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220323899/en/
COMPANY CONTACT:
Lucy O. Day
Chief Financial Officer
l.day@an2therapeutics.com
INVESTOR AND MEDIA CONTACT:
Anne Bowdidge
ir@an2therapeutics.com
Source: AN2 Therapeutics, Inc.
FAQ
When is AN2 Therapeutics (ANTX) presenting at the TD Cowen Healthcare Conference in 2025?
How long will the ANTX TD Cowen conference presentation replay be available?
Which investor conferences is AN2 Therapeutics (ANTX) attending in March 2025?
Where can investors access the webcast of ANTX's TD Cowen conference presentation?
What type of meetings is ANTX offering at the Leerink Partners Conference?
